RepliCel Life Sciences

Biotechnology Research • Vancouver, British Columbia, Canada • 1-10 Employees

Company overview

Headquarters	Suite 900, 570 Granville St, Vancouver, British Columbia V6C 3P1, CA
Phone number	+16042488730
Website	replicel.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Medical Devices, Skin Rejuvenation, Cell Therapy, Tendon Repair, Regenerative Medicine, Androgenetic Alopecia, Hair Rejuvenation, Tendinopathy, Dermal Injector, Tendinosis
Founded	2010
Employees	1-10
Socials

Key Contact at RepliCel Life Sciences

David M Hall

Chairman Of The Board Of Directors

About RepliCel Life Sciences

RepliCel Life Sciences Inc. is leading a revolution in the development of products for sports medicine and aesthetics. We are a regenerative medicine company developing innovative, clinical-stage technologies for unparalleled skin rejuvenation, tendon regeneration, and hair regrowth. RepliCel is currently involved in three clinical development programs: RCT-01 for treatment of Achilles tendinosis, RCS-01 for skin rejuvenation, and RCH-01 for treatment of Androgenic Alopecia. In Asia, RCH-01 is the subject of a co-development partnership with cosmetics and skincare giant Shiseido Company, Limited. Shiseido is currently funding a clinical study for the treatment of male and female pattern baldness (androgenic alopecia) in Japan with data anticipated in late 2018. RepliCel's nearest-term commercial asset is its next-generation dermal injector, RCI-02 which represents a medical device bringing unparalleled precision and consistency to dermal injections including shallow, even dispersion of dermal fillers for fine wrinkles. RCI-02 also promises to obviate the need for local anesthetic injections due to its patented skin-numbing element embedded in the device.

RepliCel Life Sciences revenue & valuation

Annual revenue	$269,740
Revenue per employee	$68,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$863,168
Total funding	$2,323,700

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Partner

Funding Data

Explore RepliCel Life Sciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-02-25	14	$2,100,000
2025-01-16	14	$223,700

Funding Insights

$2,323,700

Total funding amount

$223,700

Most recent funding amount

Number of funding rounds

RepliCel Life Sciences Tech Stack

Discover the technologies and tools that power RepliCel Life Sciences's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

Amazon S3

CDN

Twitter Ads

Advertising

Amazon Web Services

PaaS

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

Nginx

Reverse proxies

Slick

JavaScript libraries

Linkedin Insight Tag

Analytics

ZURB Foundation

UI frameworks

Frequently asked questions

RepliCel Life Sciences is located in Vancouver, British Columbia, CA.

You can reach RepliCel Life Sciences at +16042488730.

RepliCel Life Sciences was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

RepliCel Life Sciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

RepliCel Life Sciences has raised a total of $2,323,700 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at RepliCel Life Sciences

David M Hall

Chairman Of The Board Of Directors

4.8

40,000 users